Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 4 , Pages 261-268 , December 2007

In vitro phototoxicity of glycoconjugated porphyrins and chlorins in colorectal adenocarcinoma (HT29) and retinoblastoma (Y79) cell lines

  • Ph. Maillard, PhD

      Affiliations

    • UMR 176 CNRS, Institut Curie, Centre Universitaire, Univ Paris-Sud, Orsay, F-91405, France
    • Institut Curie, Section de Recherches, Centre Universitaire, Univ Paris-Sud, Orsay, F-91405, France
    • Corresponding Author InformationCorresponding author at: Univ Paris-Sud, UMR 176 CNRS, Institut Curie, Bâtiments 110-112, Centre Universitaire, F-91405 Orsay, France. Tel.: +33 1 69 86 31 71; fax: +33 1 69 07 53 27.
    • ,
  • B. Loock

      Affiliations

    • UMR 176 CNRS, Institut Curie, Centre Universitaire, Univ Paris-Sud, Orsay, F-91405, France
    • Institut Curie, Section de Recherches, Centre Universitaire, Univ Paris-Sud, Orsay, F-91405, France
    • ,
  • D.S. Grierson

      Affiliations

    • UMR 176 CNRS, Institut Curie, Centre Universitaire, Univ Paris-Sud, Orsay, F-91405, France
    • Institut Curie, Section de Recherches, Centre Universitaire, Univ Paris-Sud, Orsay, F-91405, France
    • ,
  • I. Laville

      Affiliations

    • BIOMOCETI, UMR CNRS 7033/Université Pierre et Marie Curie, 2 place Jussieux, Univ P. et M. Curie, Paris F-75005, France
    • ,
  • J. Blais

      Affiliations

    • BIOMOCETI, UMR CNRS 7033/Université Pierre et Marie Curie, 2 place Jussieux, Univ P. et M. Curie, Paris F-75005, France
    • ,
  • F. Doz

      Affiliations

    • Oncologie Pédiatrique, Ophtalmologie, Hôpital Cl. Regaud, 26 rue d’Ulm, Institut Curie, Paris F-75005, France
    • ,
  • L. Desjardins

      Affiliations

    • Oncologie Pédiatrique, Ophtalmologie, Hôpital Cl. Regaud, 26 rue d’Ulm, Institut Curie, Paris F-75005, France
    • ,
  • D. Carrez

      Affiliations

    • Institut Curie, Section de Recherches, Centre Universitaire, Univ Paris-Sud, Orsay, F-91405, France
    • Inserm Unité 759 Institut Curie, Centre Universitaire, Univ Paris-Sud, Orsay, F-91405, France
    • ,
  • J.-L. Guerquin-Kern

      Affiliations

    • Institut Curie, Section de Recherches, Centre Universitaire, Univ Paris-Sud, Orsay, F-91405, France
    • Inserm Unité 759 Institut Curie, Centre Universitaire, Univ Paris-Sud, Orsay, F-91405, France
    • ,
  • A. Croisy

      Affiliations

    • Institut Curie, Section de Recherches, Centre Universitaire, Univ Paris-Sud, Orsay, F-91405, France
    • Inserm Unité 759 Institut Curie, Centre Universitaire, Univ Paris-Sud, Orsay, F-91405, France

References 

  1. Wong FL, Boice JDJ, Abramson DH, et al. Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. JAMA. 1997;278:1262–1267
  2. Zucker J, Desjardins L, Doz F. Pædiatric update: retinoblastoma. Eur J Cancer. 1998;34(7):1045–1049
  3. Shields CL, Mashayekhi A, Cater J, Shelil A, et al. Chemoreduction for retinoblastoma: analysis of tumor control and risk for recurrence in 475 tumors. Trans Am Ophthalmol Soc. 2004;102:35–45
  4. Desjardins L, Levy C, Labib A, et al. An experience of the use of radioactive plaques after failure of external beam radiation in the treatment of retinoblastoma. Ophthalmic Paediatr Genet. 1993;14:39–42
  5. Murphree AL, Villablanca JG, Deegan WF, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114(11):1348–1356
  6. Murray TG, Cicciarelli N, McCabe CM, Ksander B, Feuer W, Schiffman J, et al. In vitro efficacy of carboplatin and hyperthermia in a murine retinoblastoma cell line. Invest Ophthalmol Vis Sci. 1997;38:2516–2522
  7. Levy C, Doz F, Quintana E, Pacquement H, Michon J, Schlienger P, et al. Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results. Br J Ophthalmol. 1998;82:1154–1158
  8. Shields CL, Santos MCM, Diniz W, Gündüz K, Mercado G, Cater JR, et al. Thermotherapy for retinoblastoma. Arch Ophthalmol. 1999;117:885–893
  9. Nenadov Beck M, Balmer A, Dessing C, Pica A, Munier F. First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma. J Clin Oncol. 2000;18:2881–2887
  10. Lumbroso L, Doz F, Urbieta M, Levy C, Bours D, Asselai B, et al. Chemothermotherapy in the management of retinolastoma. Ophthalmology. 2002;109:1130–1136
  11. Doz F. Carboplatin in paediatrics. Bull Cancer. 2000;87:25–29
  12. Chauveinc L, Mosseri V, Quintana E, Desjardins L, Schlienger P, Doz F, et al. Osteosarcoma following retinoblastoma: age at onset and latency period. Ophthalmic Genet. 2001;22:77–88
  13. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90(12):889–905
  14. Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol. 2000;1:212–219
  15. Dolmans D, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nature Rev Cancer. 2003;3:380–387
  16. Winther J. Porphyrin photodynamic therapy in an experimental retinoblastoma model. Ophthalmic Paediatr Genet. 1987;8(1):49–52
  17. Winther J. Photodynamic therapy effect in an intraocular retinoblastoma-like tumour assessed by an in vivo to in vitro colony forming assay. Br J Cancer. 1989;59(6):869–872
  18. Horsman MR, Winther J. Vascular effects of photodynamic therapy in an intraocular retinoblastoma-like tumour. Acta Oncol. 1989;28(5):693–697
  19. Ohnishi Y, Yamana Y, Minei M. Photoradiation therapy using argon laser and a hematoporphyrin derivative for retinoblastoma. A preliminary report. Jpn J Ophthalm. 1986;30:409–419
  20. Murphree AL, Cote M, Gomer CJ. The evolution of photodynamic therapy techniques in the treatment of intraocular tumours. Photochem Photobiol. 1987;46:919–923
  21. Rivellese MJ, Baumal CR. Photodynamic therapy of eye diseases. J Ophthalmic Nurs Technol. 2000;19(3):134–141
  22. Winther JB. The effect of photodynamic therapy on a retinoblastoma-like tumour. An experimental in vitro and in vivo study on the potential use of photodynamic therapy in the treatment of retinoblastoma. Acta Ophthalmol Suppl. 1990;197:1–37
  23. Momenteau M, Oulmi D, Maillard Ph, Croisy A. In vitro photobiological activity of a new series of photosensitizers: the glycoconjugated porphyrins. In: SPIE Proc 1995; 2325 Photodynamic Therapy of Cancer II. 1995;p. 13–23
  24. Momenteau M, Maillard Ph, De Belinay M-A, et al. Tetrapyrrolic glycosylated macrocycles for an application in PDT. J Biomed Opt. 1999;4(3):298–318
  25. Maillard Ph , Guerquin-Kern J-L, Momenteau M, Gaspard S. Glycoconjugated tetrapyrrolic macrocycles. J Am Chem Soc. 1989;111:9125–9126
  26. Maillard Ph, Guerquin-Kern J-L, Huel C, Momenteau M. Glycoconjugated porphyrins. 2 Synthesis of sterically constrained polyglycosylated compounds derived from tetraphenylporphyrins. J Org Chem. 1993;58:2774–2780
  27. Oulmi D, Maillard Ph, Guerquin-Kern JL, et al. Glyconjugated porphyrins. 3 Synthesis of flat amphiphilic meso-(glycosylated-aryl)-aryl porphyrins and mixed meso-(glycosylated-aryl)-alkyl porphyrins bearing some mono and disaccharide groups. J Org Chem. 1995;60:1554–1564
  28. Laville I, Figueiredo T, Loock B, et al. Synthesis, cellular internalization and photodynamic activity of glucoconjugated derivatives of tri and tetra(meta-hydroxyphenyl)chlorins. Bioorg Med Chem. 2003;11:1643–1652
  29. Laville I, Pigaglio S, Blais JC, et al. Photodynamic efficiency of glycoconjugated polyethylene glycol porphyrins in human retinoblastoma cells. J Med Chem. 2006;49:2558–2567
  30. Laville I, Pigaglio S, Blais JC, et al. A study of the stability of tri(glucosyloxyphenyl)chlorin, a sensitizer for photodynamic therapy, in human colon tumoural cells: a liquid chromatography and MALDI-TOF mass spectrometry analysis. Bioorg Med Chem. 2004;12:3673–3682
  31. Bonnett R, Charlesworth P, Djelal BD, et al. Photophysical properties of 5, 10, 15, 20-tetrakis(m-hydroxyphenyl)porphyrin (m-THPP), 5, 10, 15, 20-tetrakis(m-hydroxyphenyl) chlorin (m-THPC), 5, 10, 15, 20-tetrakis(m-hydroxyphenyl)bacteriochlorin (m-THPBC): a comparative study. J Chem Soc Perkin Trans. 1999;2:325–328
  32. Reid T, Albert D, Rabson A, et al. Characteristics of an established cell line of retinoblastoma. J Natl Cancer Inst. 1974;53:347–360
  33. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63
  34. Hoekstra D, Duzgunes N. Lectin-carbohydrate interactions in model and biological membrane systems. Subcell Biol. 1989;14:229–278
  35. Griegel S, Rajewsky MF, Ciesiolka T, Gabius HJ. Endogenous sugar receptor (lectin) profiles of human retinoblastoma and retinoblast cell lines analyzed by cytological markers, affinity chromatography and neoglycoprotein-targeted photolysis. Anticancer Res. 1989;9:723–730
  36. Marchal S, Bezdetnaya L, Guillemin F. Modality of cell death induced by Foscan®-based photodynamic treatment in human colon adenocarcinoma cell line HT29. Biochemistry (Moscow). 2004;69(1):45–49
  37. Kessel D, Luo Y, Mathieu P, Reiners JJJ. Determinants of the apoptotic response to lysosomal photodamage. Photochem Photobiol. 2000;71(2):196–200
  38. Oleinick NL, Morris RL, Belichenko I. The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci. 2002;1:1–21

PII: S1572-1000(07)00067-1

doi: 10.1016/j.pdpdt.2007.05.001

Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 4 , Pages 261-268 , December 2007

Article Tools

* Image Usage & Resolution